Circulation, Vol 85, 1594-1603, Copyright © 1992 by American Heart Association
H Sato, M Hori, M Kitakaze, S Takashima, M Inoue, A Kitabatake and T Kamada
BACKGROUND. Adenosine attenuates beta-adrenoceptor-mediated inotropic
responses through GTP-binding protein in vitro. The goal of the present
study was to test the hypothesis that endogenous adenosine released from
the ischemic myocardium blunts the inotropic response to beta- adrenergic
stimulation. METHODS AND RESULTS. In 45 open-chest dogs, the left anterior
descending coronary artery was perfused through an extracorporeal bypass
tube from the carotid artery. Coronary perfusion pressure was reduced so
that coronary blood flow was decreased to 60% of the basal level by partial
occlusion of the bypass tube, and the reduced coronary perfusion pressure
was kept constant thereafter. Inotropic responses to isoproterenol were
assessed by fractional shortening of the myocardium in the perfused area.
After the onset of hypoperfusion, lactate extraction ratio (18.8 +/- 1.2%)
and fractional shortening (20.7 +/- 1.1%) were significantly decreased to
-8.4 +/- 8.0% and 5.9 +/- 1.5%, respectively, and coronary arteriovenous
differences of adenosine were increased from 4.6 +/- 3.6 to 89.4 +/- 10.5
pmol/ml. In the untreated condition, an intravenous infusion of
isoproterenol (150 ng/kg/min) augmented fractional shortening from 5.9 +/-
1.5% to 13.6 +/- 0.8%. When adenosine release was attenuated by
administration of prazosin (4 micrograms/kg/min i.c.) during hypoperfusion,
the response of fractional shortening to isoproterenol (from 5.3 +/- 1.2%
to 20.5 +/- 1.4%) was much greater (p less than 0.05) than that in the
untreated control condition. Exogenous administration of adenosine
significantly attenuated the inotropic response to isoproterenol in the
prazosin-treated hearts. In contrast, an adenosine receptor antagonist,
8-phenyltheophylline, also enhanced the inotropic response to
isoproterenol. The attenuation of beta- adrenoceptor-mediated inotropic
response by adenosine could not be attributed to the inhibition of
norepinephrine release from the sympathetic nerve endings, because
identical results were observed in the chemically denervated hearts.
CONCLUSIONS. Endogenous adenosine released from the ischemic myocardium
attenuates beta-adrenoceptor- mediated inotropic response in the ischemic
heart.
ARTICLES
Endogenous adenosine blunts beta-adrenoceptor-mediated inotropic response in hypoperfused canine myocardium
First Department of Medicine, School of Medicine, Osaka University, Japan.
This article has been cited by other articles:
![]() |
S. Sanada, H. Asanuma, T. Minamino, K. Node, S. Takashima, H. Okuda, Y. Shinozaki, A. Ogai, M. Fujita, A. Hirata, et al. Optimal Windows of Statin Use for Immediate Infarct Limitation: 5'-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase Circulation, October 12, 2004; 110(15): 2143 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D Kelion, T P Webb, M A Gardner, O J M Ormerod, G L Shepherd, and A P Banning Does a selective adenosine A1 receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease? Heart, February 1, 2002; 87(2): 115 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kitakaze, T. Minamino, H. Funaya, K. Node, Y. Shinozaki, H. Mori, and M. Hori Vesnarinone Limits Infarct Size via Adenosine-Dependent Mechanisms in the Canine Heart Circulation, April 15, 1997; 95(8): 2108 - 2114. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |